Templa, Zemuel Inueh A.
HRN: 19-40-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/12/2022
11/18/2022
IVT
190mg
Q8
AGE Sec To Intestinal Amebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes